Aktuellt
SENASTE
Redeye comments on aXichem’s Q3’21 report. The report did not include any major surprises, but with the increased sales and marketing activities described in the CEO statement, we argue that the company has an exciting period ahead. The share is still trading far below our Base Case.
LÄS MER
